Identification of a field isolate of Fasciola hepatica resistant to albendazole and susceptible to triclabendazole

Veterinary Parasitology

Volumn 193, Issue 1-3, 2013, Pages 105-110

  Sanabria, Rodrigo ^a   Ceballos, Laura ^b   Moreno, Laura ^b   Romero, Jorge ^a   Lanusse, Carlos ^b   Alvarez, Luis ^b  

^a UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Albendazole; Fasciola hepatica isolate; Resistance; Triclabendazole

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFONE; ALBENDAZOLE SULFOXIDE; BAXEN; OXIBENDAZOLE; TRICLABENDAZOLE; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARGENTINA; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG HALF LIFE; DRUG SENSITIVITY; FASCIOLA HEPATICA; FASCIOLIASIS; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PARASITE IDENTIFICATION; SHEEP; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT RESPONSE;

ALBENDAZOLE; ANIMALS; ANTHELMINTICS; AREA UNDER CURVE; ARGENTINA; BENZIMIDAZOLES; DRUG RESISTANCE; FASCIOLA HEPATICA; FASCIOLIASIS; HALF-LIFE; SHEEP; SHEEP DISEASES;

ANIMALIA; FASCIOLA HEPATICA; OVIS ARIES;

EID: 84873751117     PISSN: 03044017     EISSN: 18732550     Source Type: Journal    
DOI: 10.1016/j.vetpar.2012.11.033     Document Type: Article

References (40)

1. Alvarez L., Sánchez S., Lanusse C. Modified plasma and abomasal disposition of albendazole in nematode-infected sheep. Vet. Parasitol. 1997, 69:241-253.
2. Alvarez L., Sánchez S., Lanusse C. In vivo and ex vivo uptake of albendazole and its sulphoxide metabolite by cestode parasites: relationship with their kinetic behaviour in sheep. J. Vet. Pharmacol. Ther. 1999, 22:77-86.
3. Alvarez L., Mottier M., Lanusse C. Comparative assessment of the access of albendazole, fenbendazole and triclabendazole to Fasciola hepatica: effect of bile in the incubation medium. Parasitology 2004, 128:73-81.
4. Alvarez L., Solana H., Mottier L., Virkel G., Fairweather I., Lanusse C. Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes. Parasitology 2005, 131:501-510.
5. Alvarez L., Lifschitz A., Entrocasso C., Manazza J., Mottier L., Borda B., Virkel G., Lanusse C. Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs. J. Vet. Pharmacol. Ther. 2008, 31:230-239.
6. AVMA Report of the AVMA panel on euthanasia. J. Am. Vet. Med. Assoc. 2001, 218:669-696.
7. Boray J. Diseases of Domestic Animals Caused by Flukes 1994, Food and Agricultural Organization of the United Nations, Rome, Italy, 49 pp.
8. Boray J., Crowfoot P., Strong M., Allison J., Schellenbaum M., von Orelli M., Sarasin G. Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole. Vet. Rec. 1983, 113:315-317.
9. Calpovina M., Guderian R., Paredes W., Chico M., Cooper P. Treatment of human pulmonary paragonimiasis with triclabendazole: clinical tolerance and drug efficacy. Trans. R. Soc. Trop. Med. Hyg. 1998, 92:566-569.
10. Coles G.C., Stafford K.A. Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole-resistant Fasciola hepatica. Vet. Rec. 2001, 148:723-724.
11. Chambers E., Ryan L., Hoey E., Trudgett A., McFerran N., Fairweather I., Timson D. Liver fluke β-tubulin isotype 2 binds albendazole and its thus a probable target of this drug. Parasitol. Res. 2010, 107:1257-1264.
12. Devine C., Brennan G.P., Lanusse C., Alvarez L., Trudgett A., Hoey E., Fairweather I. Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica. Parasitology 2009, 136:183-192.
13. Devine C., Brennan G.P., Lanusse C., Alvarez L., Trudgett A., Hoey E., Fairweather I. Enhancement of the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica using the metabolic inhibitor ketoconazole. Parasitol. Res. 2010, 107:337-353.
14. Fairweather I. Triclabendazole: new skills to unravel an old(ish) enigma. J. Helminthol. 2005, 79:227-234.
15. Fairweather I. Liver fluke isolates: a question of provenance. Vet. Parasitol. 2011, 176:1-8.
16. Fairweather I., Boray J. Fasciolicides: efficacy, actions, resistance and its management. Vet. J. 1999, 158:81-112.
17. Ghisi M., Kaminsky R., Mäser P. Phenotyping and genotyping of Haemonchus contortus isolates reveals a new putative candidate mutation for benzimidazole resistance in nematodes. Vet. Parasitol. 2007, 144:313-320.
18. Gibaldi M., Perrier D. Pharmacokinetics 1982, Marcel Dekker, New York.
19. Kwa M.S., Veenstra J.G., Roos M.H. Benzimidazole resistance in Haemonchus contortus is correlated with a conserved mutation at amino acid 200 in beta-tubulin isotype 1. Mol. Biochem. Parasitol. 1994, 63:299-303.
20. Lacey E. The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles. Int. J. Parasitol. 1988, 18:885-936.
21. Lubega G., Prichard R. Interaction of benzimidazole anthelmintics with Haemonchus contortus tubulin: binding affinity and anthelmintic efficacy. Exp. Psychol. 1991, 73:203-213.
22. Lubega G., Prichard R. Beta-tubulin and benzimidazole resistance in the sheep nematode Haemonchus contortus. Mol. Biochem. Parasitol. 1991, 47:129-137.
23. McConville M., Brennan G.P., McCoy M., Castillo R., Hernandez-Campos A., Ibarra F., Fairweather I. Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha. Parasitology 2006, 133:195-208.
24. McKellar Q., Scott E. The benzimidazole anthelmintic agents - a review. J. Vet. Pharmacol. Ther. 1990, 13:223-247.
25. Mitchell G. Update on fasciolosis in cattle and sheep. In Pract. 2002, 24:378-385.
26. Moll L., Gaasenbeek C.P.H., Vellem P., Borgsteede F.H.M. Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The Netherlands. Vet. Parasitol. 2000, 91:153-158.
27. Moreno L., Echevarria F., Muñoz F., Alvarez L., Sanchez Bruni S., Lanusse C. Dose-dependent activity of albendazole against benzimidazole-resistant nematodes in sheep: relationship between pharmacokinetics and efficacy. Exp. Psychol. 2004, 106:150-157.
28. Mottier L., Alvarez L., Fairweather I., Lanusse C. Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect. J. Parasitol. 2006, 92:1355-1360.
29. Olaechea F., Lovera V., Larroza M., Raffo F., Cabrera R. Resistance of Fasciola hepatica against triclabendazole in cattle in Patagonia (Argentina). Vet. Parasitol. 2011, 178:364-366.
30. Overend D., Bowen F. Resistance of Fasciola hepatica to triclabendazole. Aust. Vet. J. 1995, 72:275-276.
31. Robinson M., Trudgett A., Hoey E., Fairweather I. Triclabendazole-resistant Fasciola hepatica: β-tubulin and response to in vitro treatment with triclabendazole. Parasitology 2002, 124:325-338.
32. Robinson M., Lawson J., Trudgett A., Hoey E., Fairweather I. The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica. Parasitol. Res. 2004, 92:205-210.
33. Robinson M., McFerran N., Trudgett A., Hoey L., Fairweather I. A possible model of benzimidazole binding to beta-tubulin disclosed by invoking an inter-domain movement. J. Mol. Graphics Modell. 2004, 23:275-284.
34. Ryan L.A., Hoey E., Trudgett A., Fairweather I., Fuchs M., Robinson M.W., Chambers E., Timson D.J., Ryan E., Feltwell T., Ivens A., Bentley G., Johnston D. Fasciola hepatica expresses multiple alpha- and beta-tubulin isotypes. Mol. Biochem. Parasitol. 2008, 159:73-78.
35. Silvestre A., Cabaret J. Mutation in position 167 of isotype 1 beta-tubulin gene of Trichostrongylid nematodes: role in benzimidazole resistance?. Mol. Biochem. Parasitol. 2002, 120:297-300.
36. Suárez G., Alvarez L., Castells D., Correa O., Fagiolino P., Lanusse C. Comparative drug systemic exposure and clinical efficacy against resistant nematodes in lambs treated with different albendazole formulations. J. Vet. Pharmacol. Ther. 2011, 34:557-564.
37. van Wyk J.A., Malan F.S., van Rensburg L.J., Oberem P.T., Allan M.J. Quality control in generic anthelmintics: is it adequate?. Vet. Parasitol. 1997, 72:157-165.
38. Weber P., Buscher G., Buttner D. The effects of triclabendazole on the lung fluke, Paragonimus uterobilateralis in the experimental host Sigmodon hispidus. Trop. Med. Parasitol. 1988, 39:322-324.
39. Wolstenholme A., Fairweather I., Prichard R., Von Samson-Himmelstjerna G., Sangster N. Drug resistance in veterinary parasites. Trends Parasitol. 2004, 20:469-476.
40. Wood I.B., Amaral N.K., Bairden K., Duncan J.L., Kassai T., Malone J.B., Pankavich J.A., Reinecke R.K., Slocombe O., Taylor S.M., Vercruysse J. World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) second edition of guidelines for evaluating the efficacy of anthelmintics in ruminants (bovine, ovine, caprine). Vet. Parasitol. 1995, 58:181-213.